JP2015502551A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502551A5 JP2015502551A5 JP2014548051A JP2014548051A JP2015502551A5 JP 2015502551 A5 JP2015502551 A5 JP 2015502551A5 JP 2014548051 A JP2014548051 A JP 2014548051A JP 2014548051 A JP2014548051 A JP 2014548051A JP 2015502551 A5 JP2015502551 A5 JP 2015502551A5
- Authority
- JP
- Japan
- Prior art keywords
- aggregate
- seq
- substrate
- aggregates
- standard
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims description 34
- 239000000523 sample Substances 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 2
- 239000012925 reference material Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims 4
- 239000013543 active substance Substances 0.000 claims 3
- 239000007850 fluorescent dye Substances 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 238000000386 microscopy Methods 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 238000011002 quantification Methods 0.000 claims 2
- 125000006850 spacer group Chemical group 0.000 claims 2
- 230000009870 specific binding Effects 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 230000004931 aggregating effect Effects 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 229940000635 beta-alanine Drugs 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000012512 characterization method Methods 0.000 claims 1
- 238000001800 confocal fluorescence correlation spectroscopy Methods 0.000 claims 1
- 238000001218 confocal laser scanning microscopy Methods 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 claims 1
- 238000000799 fluorescence microscopy Methods 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 229920000729 poly(L-lysine) polymer Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 208000007153 proteostasis deficiencies Diseases 0.000 claims 1
- 238000003118 sandwich ELISA Methods 0.000 claims 1
- 238000004621 scanning probe microscopy Methods 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 102100034004 Gamma-adducin Human genes 0.000 description 2
- 101000799011 Homo sapiens Gamma-adducin Proteins 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011057021.7 | 2011-12-23 | ||
| DE102011057021A DE102011057021A1 (de) | 2011-12-23 | 2011-12-23 | Verfahren zur selektiven Quantifizierung von A-Beta-Aggregaten |
| PCT/EP2012/076552 WO2013092952A2 (de) | 2011-12-23 | 2012-12-21 | Verfahren zur selektiven quantifizierung von a-beta-aggregaten |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018189249A Division JP6625709B2 (ja) | 2011-12-23 | 2018-10-04 | Ａβ凝集体の選択的定量化方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502551A JP2015502551A (ja) | 2015-01-22 |
| JP2015502551A5 true JP2015502551A5 (enExample) | 2017-03-02 |
Family
ID=47624003
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014548051A Pending JP2015502551A (ja) | 2011-12-23 | 2012-12-21 | Ａβ凝集体の選択的定量化方法 |
| JP2018189249A Expired - Fee Related JP6625709B2 (ja) | 2011-12-23 | 2018-10-04 | Ａβ凝集体の選択的定量化方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018189249A Expired - Fee Related JP6625709B2 (ja) | 2011-12-23 | 2018-10-04 | Ａβ凝集体の選択的定量化方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150024512A1 (enExample) |
| EP (1) | EP2794655B1 (enExample) |
| JP (2) | JP2015502551A (enExample) |
| CN (1) | CN104080807A (enExample) |
| BR (1) | BR112014015392A2 (enExample) |
| CA (1) | CA2858125A1 (enExample) |
| DE (1) | DE102011057021A1 (enExample) |
| DK (1) | DK2794655T3 (enExample) |
| ES (1) | ES2922201T3 (enExample) |
| IL (1) | IL232870B (enExample) |
| RU (1) | RU2642314C2 (enExample) |
| WO (1) | WO2013092952A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102013106713A1 (de) * | 2013-06-26 | 2014-12-31 | Forschungszentrum Jülich GmbH | Verfahren zur Ermittlung von Indikatoren zur Bestimmung von Krankheiten |
| WO2016053621A1 (en) * | 2014-09-16 | 2016-04-07 | Sri International | Affinity reagent and catalyst discovery though fiber-optic array scanning technology |
| DE102015003404B4 (de) * | 2015-03-18 | 2021-10-07 | Forschungszentrum Jülich GmbH | Verfahren zur Herstellung eines Standards für den Nachweis von Proteinaggregaten einer Proteinfehlfaltungserkrankung sowie Standard und dessen Verwendung |
| WO2017138497A1 (ja) * | 2016-02-08 | 2017-08-17 | シスメックス株式会社 | 被検物質の検出方法および被検物質の検出用試薬キット |
| JP6886854B2 (ja) * | 2017-04-13 | 2021-06-16 | シスメックス株式会社 | 被検物質の情報取得方法 |
| DE102017010455A1 (de) * | 2017-06-13 | 2018-12-13 | Forschungszentrum Jülich GmbH | Verfahren zum Nachweis von Aggregaten biotherapeutischer Substanzen in einer Probe |
| DE102017005543A1 (de) * | 2017-06-13 | 2018-12-13 | Forschungszentrum Jülich GmbH | Verfahren zum Nachweis von Extrazellulären Vesikeln in einer Probe |
| DE102017010842A1 (de) * | 2017-11-23 | 2019-05-23 | Forschungszentrum Jülich GmbH | Verfahren zur Quantifizierung von Proteinaggregaten einer Proteinfehlfaltungserkrankung in einer Probe |
| US20200400687A1 (en) * | 2017-12-19 | 2020-12-24 | Chase Therapeutics Corporation | Methods for developing pharmaceuticals for treating neurodegenerative conditions |
| CN111518206B (zh) | 2019-02-01 | 2022-03-29 | 长春金赛药业有限责任公司 | 人源化抗Aβ单克隆抗体及其应用 |
| DE102020114278A1 (de) | 2020-05-28 | 2021-12-02 | Forschungszentrum Jülich GmbH | Bestimmung krankheitsspezifischer Protein-Aggregate in Stuhlproben |
| DE102020003794A1 (de) * | 2020-06-25 | 2021-12-30 | Forschungszentrum Jülich GmbH | Verfahren, Verwendung des Verfahrens sowle Kit zum Nachweis von Bioindikatoren in einer Probe |
| CN116879540B (zh) * | 2023-07-13 | 2024-04-05 | 香港中文大学（深圳） | 一种神经元蛋白聚集体特异性检测试剂盒 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE462454B (sv) * | 1988-11-10 | 1990-06-25 | Pharmacia Ab | Maetyta foer anvaendning i biosensorer |
| US7427392B1 (en) * | 1994-11-14 | 2008-09-23 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| WO2005018424A2 (en) * | 2003-08-18 | 2005-03-03 | Research Foundation For Mental Hygiene, Inc. | Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits |
| US7258990B2 (en) * | 2004-08-19 | 2007-08-21 | Biocept, Inc. | Alleviation of non-specific binding in microarray assays |
| SG10201706600VA (en) * | 2005-11-30 | 2017-09-28 | Abbvie Inc | Monoclonal antibodies and uses thereof |
| CN101384279B (zh) * | 2006-02-24 | 2012-02-22 | 奇斯药制品公司 | 抗淀粉样蛋白免疫原性组合物、方法和用途 |
| WO2008070229A2 (en) * | 2006-08-28 | 2008-06-12 | Case Western Reserve University | Detection of pathogenic aggregates of protein in a sample by homologous elisa |
| SG185316A1 (en) * | 2007-10-19 | 2012-11-29 | Immunas Pharma Inc | ANTIBODY CAPABLE OF SPECIFICALLY BINDING TO Aβ OLIGOMER, AND USE THEREOF |
| US20110104821A1 (en) * | 2008-05-08 | 2011-05-05 | Takahiko Tokuda | ABeta-OLIGOMER MEASUREMENT METHOD |
| JP5720248B2 (ja) * | 2008-12-24 | 2015-05-20 | コニカミノルタ株式会社 | 表面プラズモンおよび蛍光共鳴エネルギー転移を利用した免疫アッセイ |
| US8512677B2 (en) * | 2009-04-27 | 2013-08-20 | Case Western Reserve University | Pyro-glutamate Aβ targeting agents |
| EP2534490B1 (en) * | 2010-02-09 | 2015-12-16 | Bristol-Myers Squibb Company | Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards |
-
2011
- 2011-12-23 DE DE102011057021A patent/DE102011057021A1/de not_active Ceased
-
2012
- 2012-12-21 DK DK12818996.6T patent/DK2794655T3/da active
- 2012-12-21 CA CA2858125A patent/CA2858125A1/en not_active Abandoned
- 2012-12-21 BR BR112014015392A patent/BR112014015392A2/pt not_active IP Right Cessation
- 2012-12-21 WO PCT/EP2012/076552 patent/WO2013092952A2/de not_active Ceased
- 2012-12-21 EP EP12818996.6A patent/EP2794655B1/de active Active
- 2012-12-21 RU RU2014130136A patent/RU2642314C2/ru not_active IP Right Cessation
- 2012-12-21 ES ES12818996T patent/ES2922201T3/es active Active
- 2012-12-21 US US14/366,952 patent/US20150024512A1/en not_active Abandoned
- 2012-12-21 JP JP2014548051A patent/JP2015502551A/ja active Pending
- 2012-12-21 CN CN201280064163.5A patent/CN104080807A/zh active Pending
-
2014
- 2014-05-29 IL IL232870A patent/IL232870B/en active IP Right Grant
-
2018
- 2018-10-04 JP JP2018189249A patent/JP6625709B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015502551A5 (enExample) | ||
| JP6625709B2 (ja) | Ａβ凝集体の選択的定量化方法 | |
| Kulenkampff et al. | Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases | |
| Kim et al. | Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system | |
| BRPI1007867B8 (pt) | anticorpo recombinante ou fragmento de ligação ao antígeno do mesmo, composição farmacêutica e kit compreendendo o referido anticorpo, métodos de detecção de antígeno de troponina i em uma amostra de teste e métodos in vitro de diagnóstico de síndrome coronariana aguda ou infarto do miocárdio em um paciente | |
| WO2015127183A2 (en) | Expansion microscopy | |
| König et al. | FRET–CLSM and double-labeling indirect immunofluorescence to detect close association of proteins in tissue sections | |
| Plotegher et al. | NADH fluorescence lifetime is an endogenous reporter of α-synuclein aggregation in live cells | |
| CN105358978A (zh) | 用于查明确定疾病的指示物的方法 | |
| Feldkirchner et al. | Patient‐specific protein aggregates in myofibrillar myopathies: laser microdissection and differential proteomics for identification of plaque components | |
| KR101612095B1 (ko) | 바이오마커의 조기 검출 및 정밀 정량화가 가능한 바이오마커 탐지용 프로브 및 이의 용도 | |
| Gupta et al. | Epitope imprinting of iron binding protein of Neisseria meningitidis bacteria through multiple monomers imprinting approach | |
| JP2015502968A (ja) | 生体固有のタンパク質からの病原性の凝集体を定量化するための標準物質 | |
| Chien et al. | Exploring the formation of focal adhesions on patterned surfaces using super‐resolution imaging | |
| KR101492167B1 (ko) | 페리틴 단백질을 함유하는 표적-특이적 프로브 및 이를 이용한 바이오마커의 탐지 | |
| US20230228771A1 (en) | Determination of disease-specific protein aggregates in stool samples | |
| Abdul‐Rahman et al. | The potential of phosphorylated α‐synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy | |
| JPWO2005093430A1 (ja) | 蛋白質のアミロイド性の構造変化を検出する方法、アミロイド性の構造変化に影響を与える活性を有する物質を探索する方法、アミロイド関連疾患の治療薬又は診断薬を探索する方法 | |
| KR102328709B1 (ko) | 저분자 아밀로이드 베타 검출용 펩타이드 및 이의 용도 | |
| JP2020523554A (ja) | 試料中におけるバイオ治療物質凝集体の検出方法 | |
| CN111527409A (zh) | 将样品中蛋白错误折叠疾病的蛋白聚集体定量的方法 | |
| Martinez-Valbuena et al. | A novel approach to evaluate alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy | |
| Zhou et al. | Retractable DNA Nanoprobes for Ultrasensitive SERS Detection and Imaging of the VEGF | |
| Awawdeh et al. | Porous silicon biosensors meet zwitterionic peptides: tackling biofouling from proteins to cells | |
| Zhu | Detection Techniques for Molecular Interactions Based on Interferometry and Microcantilever |